Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic DifferentiationMaría E. Figueroa, Ari Melnick, Wei Liu et al.|Cancer Cell|2010Cited by 2.7k
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemiaMark A. Dawson, Tony Kouzarides, Rab K. Prinjha et al.|Nature|2011Cited by 1.5k
Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemiaBas J. Wouters, Ruud Delwel|Blood|2015Cited by 298
PBX3 is an important cofactor of HOXA9 in leukemogenesisZejuan Li, Jianjun Chen, Zhiyu Zhang et al.|Blood|2012Cited by 170
High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcomeMartine E.D. Chamuleau, G.J. Ossenkoppele, Arjan A. van de Loosdrecht et al.|Haematologica|2008Cited by 85